Outcomes of reimplantation of a new Glaucoma Drainage Device after explantation of an older implant from exposure-related complications

Author:

Yaswanth Tiruveedhi S1,Roy Avik K2,Senthil Sirisha D3,Krishnamurthy Rashmi S3

Affiliation:

1. Glaucoma Services, L.V Prasad Eye Institute, Vishakhapatnam, Andhra Pradesh, India

2. Glaucoma Services, L.V Prasad Eye Institute, Bhubaneswar, Odisha, India

3. Glaucoma Services L.V Prasad Eye Institute, Hyderabad, Telangana, India

Abstract

Purpose: To describe the clinical outcome of a series of seven eyes with an explanation of an original Glaucoma Drainage Device (GDD) arising from the complication of plate exposure and consequent reimplantation of another GDD at a second setting. Methods: This was a retrospective, interventional, and non-comparative study at two tertiary eye care hospitals in eastern and southern India. Electronic medical record data of the seven eyes where a GDD was explanted and a 2nd GDD was reimplanted over October 2010 and May 2021 was analyzed. Statistical analysis was done by SPSS (ver. 26). Results: The first GDD survived for a mean of 168 days only till the plate got exposed and thereby got explanted. Possible predisposing factors noted were conjunctival and scleral thinning, ischemic conjunctiva, etc., The reimplantation surgery was technically easy in the absence of hypotony—opposite to what is reported in the literature. The final IOP (mean +/− SD) values (mm Hg) were 18.9 (+/−7.9), range = 10–30. The mean number of glaucoma medications reduced from 3.9 (+/−1.2; range, 2 to 5) after the explanation to 3.1 (+/−0.7; range, 2 to 4) after the 2nd GDD implantation, in the final follow-up. The second GDD was found to be stable till the last follow-up (mean = 1149 days). No other significant intraoperative or postoperative complications were seen. Conclusions: Reimplantation of a second GDD in a separate setting after explanations of an original implant due to exposure-related complication is both a safe and effective method.

Publisher

Medknow

Subject

Ophthalmology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3